| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |